Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kansas Sci-Tech Reporter.
Press releases published on September 11, 2025
Le fonds Sarat Ventures Y Innovations Biotech Fund prévoit d’investir dans des entreprises en phase de démarrage, plus particulièrement en Arabie saoudite et dans la région MENA
GlobeNewswire
·
September 11, 2025
LONDRES, 11 sept. 2025 (GLOBE NEWSWIRE) -- Dans le cadre d’une initiative historique visant à positionner l’Arabie saoudite comme un pôle mondial de la biotechnologie, le fonds Sarat Ventures Y Innovations Biotech Fund (Royaume-Uni) a annoncé aujourd’hui …
Sarat Ventures Y Innovations Biotech Fund invertirá en empresas en etapa inicial con enfoque en Arabia Saudita y en la región MENA
GlobeNewswire
·
September 11, 2025
LONDRES, Sept. 11, 2025 (GLOBE NEWSWIRE) -- En un paso histórico hacia el posicionamiento de Arabia Saudita como un centro mundial de biotecnología, Sarat Ventures Y Innovations Biotech Fund (Reino Unido) anunció hoy el lanzamiento de un fondo de …
קרן הביוטק Sarat Ventures Y Innovations תשקיע בחברות בשלבים מוקדמים עם דגש על ערב הסעודית ואזור המזרח התיכון וצפון אפריקה
GlobeNewswire
·
September 11, 2025
לונדון, Sept. 11, 2025 (GLOBE NEWSWIRE) -- בצעד היסטורי לקראת מיצוב ערב הסעודית כמרכז עולמי לביוטכנולוגיה, Sarat Ventures Y Innovations Biotech Fund (בריטניה) הודיעה היום על השקת קרן ביוטכנולוגיה, המעוגנת על ידי Allocator One, שצפויה להשקיע כ-50 מיליון …
サラット・ベンチャーズYイノベーションズ・バイオテック・ファンド (Sarat Ventures Y Innovations Biotech Fund)、サウジアラビアおよび中東・北アフリカ地域を中心とした初期段階の企業へ投資
GlobeNewswire
·
September 11, 2025
ロンドン発 , Sept. 12, 2025 (GLOBE NEWSWIRE) -- サウジアラビアをバイオテクノロジーの世界的拠点として位置付けるための歴史的な一歩として、サラット・ベンチャーズYイノベーションズ・バイオテック・ファンド (英国) は本日、アロケーター・ワン (Allocator One) を中核とするバイオテック・ファンドの設立を発表した。同ファンドは、サウジアラビア市場および周辺の中東・北アフリカ (MENA) 地域との戦略的つながりを持つバイオテクノロジー企業に対し、約5,000 …
Sarat Ventures Y Innovations Biotech Fund, 사우디아라비아 및 MENA 지역 중심의 초기 단계 기업에 투자
GlobeNewswire
·
September 11, 2025
런던, Sept. 12, 2025 (GLOBE NEWSWIRE) -- 사우디아라비아를 글로벌 바이오테크 허브로 자리매김하기 위한 역사적 행보의 일환으로 Sarat Ventures Y Innovations Biotech Fund (UK)가 오늘 바이오테크 펀드의 출범을 발표했다. 이 펀드는 Allocator One이 앵커 투자자로 참여하며, 사우디아라비아 시장 및 광범위한 MENA(중동·북아프리카) 지역과 전략적 연계가 있는 바이오테크 기업들에 약 5천만 …
Sarat Ventures Y Innovations Biotech Fund akan Melabur dalam Syarikat Peringkat Awal di Arab Saudi dan Rantau MENA
GlobeNewswire
·
September 11, 2025
LONDON, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Dalam satu langkah bersejarah ke arah menjadikan Arab Saudi sebagai hab global dalam bidang bioteknologi, Sarat Ventures Y Innovations Biotech Fund (UK) hari ini mengumumkan pelancaran dana bioteknologi baharu …
Sarat Ventures Y Innovations Biotech Fund Irá Investir em Empresas em Estágio Inicial com Foco na Arábia Saudita e na região MENA
GlobeNewswire
·
September 11, 2025
LONDRES, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Em um passo histórico para posicionar a Arábia Saudita como um centro global de biotecnologia, o Sarat Ventures Y Innovations Biotech Fund (Reino Unido) anunciou hoje a criação de um fundo de biotecnologia, …
Sarat Ventures Y Innovations Biotech Fund将重点投资沙特阿拉伯及中东和北非地区初创企业
GlobeNewswire
·
September 11, 2025
伦敦, Sept. 12, 2025 (GLOBE NEWSWIRE) -- 为推动沙特阿拉伯成为全球生物技术枢纽迈出历史性一步，Sarat Ventures Y Innovations Biotech Fund (UK)今日宣布推出生物技术基金，该基金由Allocator One主导，预计将向与沙特阿拉伯市场及更广泛的中东和北非地区具有战略联系的生物技术公司投资约5000万美元。 这项倡议由Y Innovations Group旗下子公司Yung Ventures的普通合伙人Megan Yung …
Sarat Ventures Y Innovations 生物科技基金致力投資初創企業，重點關注沙特阿拉伯及中東和北非 (MENA) 地區
GlobeNewswire
·
September 11, 2025
倫敦, Sept. 12, 2025 (GLOBE NEWSWIRE) -- 在將沙特阿拉伯打造為全球生物科技中心的歷史性進程中，Sarat Ventures Y Innovations 生物科技基金（英國）今日宣佈成立由 Allocator One 領銜的生物科技基金，預計將向與沙特阿拉伯市場及更廣泛中東和北非地區具策略連繫的生物科技公司投資約 5,000 萬美元。 此計劃由 Y Innovations 集團公司 Yung Ventures 的 Megan Yung …
Dayforce Named a Leader in the 2025 Gartner® Magic Quadrant™ for HCM Suites for 1,000+ Employee Enterprises for Sixth Consecutive Year
GlobeNewswire
·
September 11, 2025
MINNEAPOLIS and TORONTO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced it has been named a Leader in the 2025 Gartner Magic Quadrant for …
Aligned Data Centers Donates $100,000 to mikeroweWORKS Foundation, Championing Skilled Trades and Future Workforce Development
GlobeNewswire
·
September 11, 2025
DALLAS, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Aligned Data Centers (“Aligned” or the “Company”), a leading provider of Gigascale, Build-to-Scale, and Multi-tenant data center solutions supporting hyperscale, neocloud, and enterprise customers' most demanding …
ASUS Listed on TIME’s World’s Best Companies 2025 for the Second Time
GlobeNewswire
·
September 11, 2025
KEY POINTS TIME recognition: ASUS secures its second inclusion on TIME’s World’s Best Companies that set the standard in innovation, growth, employee satisfaction A commitment to innovation: ASUS validated for its leadership in fostering a great workplace, …
iPhone 17 Protection, Built for You, From Urban Armor Gear
GlobeNewswire
·
September 11, 2025
Irvine, California, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Orange County, Calif. (Sept. 9th, 2025) – Urban Armor Gear (UAG), leading designer of rugged, lightweight mobile device cases, power and accessories, is excited to announce the launch of its latest …
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer
GlobeNewswire
·
September 11, 2025
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer A total of 105 HLA-A2 positive …
OSE Immunotherapeutics et la Fondation FoRT annoncent la fin du recrutement dans Combi-TED, l’étude clinique de Phase 2 évaluant Tedopi® en combinaison avec nivolumab ou docétaxel dans le cancer du poumon non à petites cellules
GlobeNewswire
·
September 11, 2025
OSE Immunotherapeutics et la Fondation FoRT annoncent la fin du recrutement dans Combi-TED, l’étude clinique de Phase 2 évaluant Tedopi® en combinaison avec nivolumab ou docétaxel dans le cancer du poumon non à petites cellules Un total de 105 patients HLA …
Lightcast and Carahsoft Partner to Bring Data-Driven Workforce Strategies to the Public Sector
GlobeNewswire
·
September 11, 2025
MOSCOW, Idaho, and RESTON, Va., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Lightcast, a global leader in labor market analytics, and Carahsoft Technology Corp., The Trusted Government IT Solutions Provider®, today announced a partnership. Under the agreement, …
Faraday Pharmaceuticals to Participate in Upcoming Investor Events
GlobeNewswire
·
September 11, 2025
SEATTLE, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) through the …
RESTEM to Host R&D Day Highlighting its Next-Generation Immunomodulatory Treatment for Autoimmune and Inflammatory Diseases
GlobeNewswire
·
September 11, 2025
Leading KOLs to discuss the unmet needs and current treatment landscapes of idiopathic inflammatory myopathy (IIM), ulcerative colitis (UC), rheumatoid arthritis (RA), and facioscapulohumeral muscular dystrophy (FSHD) In-person and virtual R…
Hume Health Body Pod Official Launch — Advanced Full Body Composition Analyzer
GlobeNewswire
·
September 11, 2025
New York City, NY, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Introduction — What Is the Hume Health Body Pod? Hume Health has officially launched the much-anticipated Body Pod — an advanced smart body composition analyzer built to transform how people track their …
SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025
GlobeNewswire
·
September 11, 2025
Press release – No.13 / 2025 SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025 Copenhagen, Denmark, September 11, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the …